DOI QR코드

DOI QR Code

Clear Cell Borderline Tumor of the Ovary: A Case Report

난소에 발생한 경계성 투명세포종: 증례 보고

  • Ha Jung Kim (Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine) ;
  • Kyeong Ah Kim (Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine) ;
  • Yikyeong Chun (Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine) ;
  • Yang Shin Park (Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine) ;
  • Mi Jin Song (Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine) ;
  • Jae Woong Choi (Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine)
  • 김하정 (고려대학교 의과대학 고려대학교 구로병원 영상의학과) ;
  • 김경아 (고려대학교 의과대학 고려대학교 구로병원 영상의학과) ;
  • 전이경 (고려대학교 의과대학 고려대학교 구로병원 병리과) ;
  • 박양신 (고려대학교 의과대학 고려대학교 구로병원 영상의학과) ;
  • 송미진 (고려대학교 의과대학 고려대학교 구로병원 영상의학과) ;
  • 최재웅 (고려대학교 의과대학 고려대학교 구로병원 영상의학과)
  • Received : 2022.08.19
  • Accepted : 2022.10.02
  • Published : 2023.05.01

Abstract

Clear cell borderline ovarian tumor (CCBOT) is quite rare, and only a few cases of CCBOT have been reported. Unlike most borderline ovarian tumors, CCBOTs appear solid because they are almost always pathologically adenofibromatous. Herein, we report the MRI findings of a CCBOT discovered in a 22-year-old female.

난소의 경계성 투명 세포 종양은 매우 드문 종양으로 현재까지 몇 개의 증례만 보고되었다. 일반적인 경계성 종양과 달리 경계성 투명 세포 종양은 고형의 종괴로 보이는데 병리학적으로 거의 대부분 선섬유성이기 때문이다. 저자들은 22세 여성의 난소에서 생긴 경계성 투명세포 종양의 자기공명영상 소견에 대하여 보고하고자 한다.

Keywords

References

  1. Ricotta G, Maulard A, Candiani M, Genestie C, Pautier P, Leary A, et al. Clear cell borderline ovarian tumor: clinical characteristics, prognosis, and management. Ann Surg Oncol 2022;29:1165-1170
  2. Zhao C, Wu LS, Barner R. Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer 2011;2:94-106
  3. Kleebkaow P, Aue-Aungkul A, Temtanakitpaisan A, Kietpeerakool C. Borderline clear cell adenofibroma of the ovary. Case Rep Pathol 2017;2017:3860107
  4. Vasenwala SM, Ansari HA, Haider N, Rehman S, Khan T. Atypical proliferating clear cell adenofibroma of the ovary: a case report. Middle East J Cancer 2013;4:87-90
  5. Alves AS, Felix A, Cunha TM. Clues to the diagnosis of borderline ovarian tumours: an imaging guide. Eur J Radiol 2021;143:109904
  6. Lee HJ, Kim TJ, Kim JN, Seo EJ, Lee KY. Borderline clear cell adenofibromatous tumors of the ovary: two case reports. Korean J Pathol 2007;41:420-423
  7. Foti PV, Attina G, Spadola S, Caltabiano R, Farina R, Palmucci S, et al. MR imaging of ovarian masses: classification and differential diagnosis. Insights Imaging 2016;7:21-41
  8. Kato H, Kanematsu M, Ono H, Yano R, Furui T, Morishige K, et al. Ovarian fibromas: MR imaging findings with emphasis on intratumoral cyst formation. Eur J Radiol 2013;82:e417-e421
  9. Montoriol PF, Hordonneau C, Boudinaud C, Molnar I, Abrial C, Kossai M. Benign Brenner tumour of the ovary: CT and MRI features. Clin Radiol 2021;76:593-598
  10. Oh SN, Rha SE, Byun JY, Lee YJ, Jung SE, Jung CK, et al. MRI features of ovarian fibromas: emphasis on their relationship to the ovary. Clin Radiol 2008;63:529-535